Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML
| Main Authors: | , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
Springer Science and Business Media LLC
2020
|
| Online Access: | https://hdl.handle.net/1721.1/126001 |
| _version_ | 1811071885330350080 |
|---|---|
| author | Benajiba, Lina Alexe, Gabriela Su, Angela Raffoux, Emmanuel Soulier, Jean Hemann, Michael Hermine, Olivier Itzykson, Raphael Stegmaier, Kimberly Puissant, Alexandre |
| author2 | Koch Institute for Integrative Cancer Research at MIT |
| author_facet | Koch Institute for Integrative Cancer Research at MIT Benajiba, Lina Alexe, Gabriela Su, Angela Raffoux, Emmanuel Soulier, Jean Hemann, Michael Hermine, Olivier Itzykson, Raphael Stegmaier, Kimberly Puissant, Alexandre |
| author_sort | Benajiba, Lina |
| collection | MIT |
| first_indexed | 2024-09-23T08:57:30Z |
| format | Article |
| id | mit-1721.1/126001 |
| institution | Massachusetts Institute of Technology |
| language | English |
| last_indexed | 2024-09-23T08:57:30Z |
| publishDate | 2020 |
| publisher | Springer Science and Business Media LLC |
| record_format | dspace |
| spelling | mit-1721.1/1260012022-09-26T09:28:52Z Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML Benajiba, Lina Alexe, Gabriela Su, Angela Raffoux, Emmanuel Soulier, Jean Hemann, Michael Hermine, Olivier Itzykson, Raphael Stegmaier, Kimberly Puissant, Alexandre Koch Institute for Integrative Cancer Research at MIT 2020-06-26T17:36:53Z 2020-06-26T17:36:53Z 2018-11 2018-08 2019-12-05T17:38:07Z Article http://purl.org/eprint/type/JournalArticle 0887-6924 1476-5551 https://hdl.handle.net/1721.1/126001 Benajiba, L. et al. "Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML." Leukemia 33, 3 (November 2018): 800–804 © 2018 Springer Nature en http://dx.doi.org/10.1038/s41375-018-0291-x Leukemia Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf Springer Science and Business Media LLC PMC |
| spellingShingle | Benajiba, Lina Alexe, Gabriela Su, Angela Raffoux, Emmanuel Soulier, Jean Hemann, Michael Hermine, Olivier Itzykson, Raphael Stegmaier, Kimberly Puissant, Alexandre Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML |
| title | Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML |
| title_full | Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML |
| title_fullStr | Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML |
| title_full_unstemmed | Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML |
| title_short | Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML |
| title_sort | creatine kinase pathway inhibition alters gsk3 and wnt signaling in evi1 positive aml |
| url | https://hdl.handle.net/1721.1/126001 |
| work_keys_str_mv | AT benajibalina creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml AT alexegabriela creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml AT suangela creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml AT raffouxemmanuel creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml AT soulierjean creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml AT hemannmichael creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml AT hermineolivier creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml AT itzyksonraphael creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml AT stegmaierkimberly creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml AT puissantalexandre creatinekinasepathwayinhibitionaltersgsk3andwntsignalinginevi1positiveaml |